StocksMediumUpdated•Originally published 21 October 2026•Updated 21 October 2026•
1 min read
Danaher and Integra LifeSciences Report Q3 2026 Financial Results
Key Facts
1Danaher Corporation announced its third quarter 2026 financial results for continuing operations.
2Integra LifeSciences Holdings Corporation reported financial results for the third quarter ending September 30, 2026.
Danaher Corporation reported non-GAAP earnings per share of $2.11 for the third quarter of 2026, beating analyst estimates by $0.19, according to a statement via PR Newswire. Revenue for the period reached $6.55 billion, missing expectations by $10 million, as Integra LifeSciences Holdings Corporation also released its financial results for the quarter ending September 30, 2026, via GlobeNewswire.
Danaher increased its full-year 2026 adjusted diluted net earnings guidance to a range of $8.57 to $8.62 per share, up from the previously forecast range of $8.45 to $8.60. Regarding market performance, DHR closed at $224.24 on October 20, 2026, while IART closed at $13.33 on the same date.